Immunovant, Inc.
IMVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764013
In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Immunovant, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 118 | 112 | −6 |
| Shares | 37.8M | 39.6M | +1.71M (+4.5%) |
| Value | $322.4M | $218.6M | −$103.9M (−32.2%) |
New holders (13)
Institutions that held Immunovant, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 585,759 | $3.23M | 0.28% |
| Algert Global LLC | 136,327 | $751.0K | 0.05% |
| IndexIQ Advisors LLC | 71,281 | $393.0K | 0.01% |
| Qube Research & Technologies Ltd | 35,382 | $195.0K | 0.00% |
| Bridgefront Capital, LLC | 19,002 | $105.0K | 0.13% |
| Balyasny Asset Management LLC | 14,616 | $81.0K | 0.00% |
| Prospera Financial Services Inc | 9,135 | $50.0K | 0.00% |
| Amalgamated Bank | 5,943 | $33.0K | 0.00% |
| Amalgamated Financial Corp. | 5,943 | $33.0K | 0.00% |
| FMR LLC | 893 | $5.00K | 0.00% |
| Lindbrook Capital, LLC | 289 | $2.00K | 0.00% |
| Heritage Wealth Management, LLC | 150 | $1.00K | 0.00% |
| IFP Advisors, Inc | 10 | – | – |
Sold out (19)
Institutions that held Immunovant, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| EcoR1 Capital, LLC | 1,140,819 | $9.72M |
| Frazier Management LLC | 585,759 | $4.99M |
| Rafferty Asset Management, LLC | 189,926 | $1.62M |
| Voloridge Investment Management, LLC | 180,395 | $1.54M |
| UBS Group AG | 166,534 | $1.42M |
| Gsa Capital Partners LLP | 40,654 | $346.0K |
| Walleye Capital LLC | 32,956 | $281.0K |
| Occudo Quantitative Strategies LP | 24,427 | $208.0K |
| D. E. Shaw & Co., Inc. | 20,371 | $174.0K |
| Weiss Asset Management LP | 19,897 | $170.0K |
| Quantbot Technologies LP | 16,213 | $138.0K |
| SG Americas Securities, LLC | 15,032 | $128.0K |
| Wells Fargo & Company | 12,423 | $105.0K |
| Fox Run Management, L.L.C. | 10,803 | $92.0K |
| Marshall Wace, LLP | 8,316 | $71.0K |
| Simplex Trading, LLC | 4,019 | $34.0K |
| Signaturefd, LLC | 840 | $7.00K |
| Parallel Advisors, LLC | 382 | $3.00K |
| Umb Bank N A | 141 | $1.00K |